Project Grant R01DK138605
Award Date
8/2/24
Completion Date
5/31/27
Dollars Obligated
$2.2M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This federal Project Grant award, valued at $567,643.00 and spanning September 2024 through May 2029, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research at Duke University focused on understanding the communication between alpha and beta cells, and its role in insulin secretion and glucose homeostasis, particularly in the context of...
This $205,280 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports a research project investigating the mechanisms driving the kinetics of incretin-mediated beta cell responses. The project aims to quantify the trafficking of incretin receptors and their influence on cAMP responses, as well as examine the interplay between cAMP and...
This federal Project Grant award of $444,867.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to investigate the role of the UPR transducer XBP1 in pancreatic beta cell survival and function under metabolic stress. The research will use a novel mouse model to elucidate the pathological role of XBP1s in beta cell integrity under metabolic stress, in order to...
The federal Project Grant award R01DK139146, titled "Reprogramming Glutamine Metabolism in Pancreatic Beta Cells", is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $1,349,491 award supports research to uncover the mechanisms by which the transaminase GPT2 promotes pancreatic beta cell dysfunction and death, and how GPT2 influences the sensitivity of...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $392,258 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Joslin Diabetes Center, Inc. This grant will fund the Joslin-BIDMC Post-Bac Program in Diabetes and Metabolism. The program aims to attract talented individuals from diverse backgrounds to pursue further training and careers in biomedical research focused on metabolic diseases. Key program...
This $698,646 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to study the functional and disease relevance of distinct pancreatic beta-cell subtypes, with a focus on understanding their epigenetic regulation and relationship to type 2 diabetes (T2D). The research will use novel single-cell epigenomic tools, conditional...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Brigham Young University a $568,075 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research to determine the role of the NR4A1 protein in regulating the GLP-1R and DYRK1A pathways, which are critical for expanding functional beta-cell mass as a potential treatment for type 1 and type 2 diabetes. The research aims to elucidate the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $194,616 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Weill Medical College of Cornell University. The grant aims to examine the impact of in vivo activation of the transcription factor ATF6 on pancreatic beta cell function, specifically in relation to insulin production and secretion. The research will contribute to the understanding of the...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,338,684 to Yale University to conduct a longitudinal study utilizing PET and MRI techniques. The goal is to assess insulin vesicle functional capacity, beta cell mass, and pancreas volume in individuals at risk for and with recent onset type 1 diabetes. The study aims to...
This $1,331,148 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to investigate the mechanisms by which pancreatic alpha cells can compensate for deficiencies in beta cell mass in type 2 diabetes. The key objectives are to: 1) Determine the signaling mechanisms underlying beta cell compensation in a mouse model of beta cell...